Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures
AbstractThe regulation of thrombin activity offers an opportunity to regulate blood clotting because of the central role played by this molecule in the coagulation cascade. Thrombin-binding DNA aptamers have been used to inhibit thrombin activity. In the past, to address the low efficacy reported for these aptamers during clinical trials, multiple aptamers have been linked using DNA nanostructures. Here, we modify that strategy by linking multiple copies of various thrombin-binding aptamers using DNA weave tiles. The resulting constructs have very high anticoagulant activity in functional assays owing to their improved cooperative binding affinity to thrombin due to optimized spacing, orientation, and the high local concentration of aptamers. We also report the results of molecular dynamics simulations to gain insight into the solution conformations of the tiles. Moreover, by using DNA strand displacement, we were able to turn the coagulation cascade off and on as desired, thereby enabling significantly better control over blood coagulation. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 973 KB)
Share & Cite This Article
Rangnekar, A.; Nash, J.A.; Goodfred, B.; Yingling, Y.G.; LaBean, T.H. Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures. Molecules 2016, 21, 202.
Rangnekar A, Nash JA, Goodfred B, Yingling YG, LaBean TH. Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures. Molecules. 2016; 21(2):202.Chicago/Turabian Style
Rangnekar, Abhijit; Nash, Jessica A.; Goodfred, Bethany; Yingling, Yaroslava G.; LaBean, Thomas H. 2016. "Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures." Molecules 21, no. 2: 202.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.